2020 Scientific Sessions

Featured Clinical Research

Safety and Efficacy of the Biodegradable-Polymer Everolimus-Eluting Stent vs.Durable-Polymer Drug-Eluting Stents in High-Risk Patients Undergoing PCI: Insights From the TWILIGHT Trial
Usman Baber, M.D.1, George D. Dangas, M.D., Ph.D., MSCAI2, Samin K. Sharma, M.D., MSCAI3, Rishi Chandiramani, M.D.3, Shamir Mehta, M.D., M.Sc.4, Carlo Briguori, M.D., Ph.D., FSCAI5, Javier Escaned, M.D., Ph.D.6, Kurt Huber, M.D.7, Vijay Kunadian, M.B.B.S., M.D.8, Keith G. Oldroyd, M.B.Ch.B., M.D. (Hons)9 and Roxana Mehran, M.D., MSCAI3, (1)The University Of Oklahoma Health Sciences Center, Oklahoma City, OK, (2)Mount Sinai Hospital, New York, NY, (3)Icahn School of Medicine at Mount Sinai, New York, NY, (4)McMaster University, Hamilton, ON, CANADA, (5)Clinica Mediterranea, Naples, Campania, Italy, (6)Hospital Clínico San Carlos, Madrid, Spain, (7)Wilhelminenspital, Vienna, Austria, (8)Newcastle upon Tyne Hospitals, Middlesbrough, United Kingdom, (9)Golden Jubilee National Hospital, Glasgow, United Kingdom
Reduction of Revascularizations in Patients with Hypertriglyceridemia With Icosapent Ethyl: Insights From REDUCE-IT REVASC
Benjamin E Peterson, M.D.1, Deepak L. Bhatt, M.D., M.P.H., MSCAI1, Philippe Gabriel Steg, M.D.2, Michael Miller, M.D.3, Eliot A. Brinton, M.D.4, Terry A Jacobson, M.D.5, Steven B Ketchum, Ph.D.6, Rebecca A Juliano, Ph.D.6, Lixia Jiao, Ph.D.6, Ralph T Doyle, B.A.7, Craig Granowitz, M.D., Ph.D.7, C. Michael Gibson, M.D., MSCAI8, Duane S. Pinto, M.D., M.P.H.9, Robert P. Giugliano, M.D.1, Matthew J. Budoff, M.D.10, Jean-Claude Tardif, M.D.11, Subodh Verma, M.D., Ph.D.12 and Christie Ballantyne13, (1)Brigham and Women's Hospital, Boston, MA, (2)Université Paris Cité, Paris, France, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of Utah School of Medicine, Salt Lake City, UT, (5)Emory University, Atlanta, GA, (6)-, Bedminster, NJ, (7)Amarin Pharma Inc., Bedminster, NJ, (8)Beth Israel Deaconess Medical Center, Natick, MA, (9)Beth Israel Deaconess Medical Center, Boston, MA, (10)Harbor–UCLA Medical Center, Los Angeles, CA, (11)Montreal Heart Institude, Montreal, QC, Canada, (12)St. Michael's Hospital, Toronto, ON, Canada, (13)Baylor College of Medicine, Houston, TX
Autologous CD34 Cell Therapy for Treatment of Coronary Microvascular Dysfunction in Patients With Angina and Non-Obstructive Coronary Arteries
Timothy D. Henry, M.D., MSCAI1, Amir Lerman, M.D.2, Janet Wei, M.D.3, Michel T. Corban, M.D., FSCAI4, Sandy Joung3, Christine Kotynski, BS5, Michelle Lewis6, Ann Schumacher, MSN5, Vishal Shah6, Ronnda Bartel6, Jian Wang, MS5, William K Sietsema, Ph.D.7, Douglas W. Losordo, M.D., FACC, FAHA8 and C Noel Bairey Merz, M.D., FACC, FAHA9, (1)The Christ Hospital Health Network, Covington, KY, (2)Mayo Clinic Health System Rochester, Rochester, CT, (3)Cedars- Sinai Medical Center, Los Angeles, CA, (4)University of Arizona College of Medicine – Tucson, Tucson, AZ, (5)-, Rye Brook, NY, (6)Caladrius Biosciences, Rye Brook, NY, (7)Caladrius Biosciences, Basking Ridge, NY, (8)Caladrius Biosciences, Scarsdale, NY, (9)Barbara Streisand Women's Heart Center (Cedars Sinai), Los Angeles, CA
Outcomes with Intermediate Left Main Disease on Coronary CT Angiography in the ISCHEMIA Trial (ISCHEMIA Intermediate LM Substudy)
Sripal Bangalore, MD, MHA, FSCAI1, John A. Spertus, M.D.2, Susanna R. Stevens, M.S.3, Philip G. Jones, M.S.4, G.B. John Mancini, M.D.5, Jonathon Leipsic, M.D.6, Harmony R. Reynolds, MD1, Matthew J. Budoff, M.D.7, Cameron J. Hague, M.D.8, JAMES K Min, MD9, William E. Boden, M.D.10, Sean M. O'Brien, PhD3, Robert A. Harrington, M.D., FSCAI11, Jeffrey S. Berger, M.D.1, Roxy Senior, MBBS, MD, DM12, Jesus Peteiro, MD, PhD13, Neeraj Pandit, M.D., FSCAI14, Leonid Bershtein, M.D.15, Mark A. de Belder, M.D.16, Hanna Szwed, MD, PhD17, Rolf Doerr, M.D.18, Lorenzo Monti, M.D.19, Khaled Alfakih, MBBS, MD20, Judith S. Hochman, M.D.1 and David J. Maron, M.D.21, (1)NYU Grossman School of Medicine, New York, NY, (2)Saint Luke's Mid America Heart Institute, Kansas City, MO, (3)Duke Clinical Research Institute, Durham, NC, (4)Saint Luke’s Mid America Heart Institute, Kansas City, MO, (5)University of British Columbia, Vancouver, BC, Canada, (6)Providence Health Care, Vancouver, BC, Canada, (7)Harbor–UCLA Medical Center, Torrance, CA, (8)University of British Columbia, St. Paul's Hospital Department of Radiology, Vancouver, BC, Canada, (9)Weill Cornell Medicine | NewYork-Presbyterian, NewYork, NY, (10)VA New England Healthcare System, Boston, MA, (11)Weill Cornell Medicine, New York, NY, (12)Northwick Park Hospital Harrow/ Royal Brompton Hospital London, London, United Kingdom, (13)Complejo Hospitalario Universitario de A Coruna, A Coruna, Spain, (14)PGIMER DR.RML HOSPITAL, New Dehli, Delhi, India, (15)North-Western State Medical University named after I.I Mechnikov, Saint Petersburg, Russian Federation, (16)Barts Health NHS Trust, London, United Kingdom, (17)National Institute of Cardiology, Warsaw, Poland, (18)Praxisklinik Herz und Gefaesse, Dresden, Germany, (19)Istituto Clinico Humanitas, Rozzano, Italy, (20)King's College Hospital, London, United Kingdom, (21)Department of Medicine, Stanford University, Stanford, CA
Optical Coherence Tomography Measures Predicting Fractional Flow Reserve: The OMEF Study
Rocco Vergallo, M.D.1, Francesco Burzotta, MD, PhD2, Tsunekazu Kakuta3, Tomasz Pawlowski, MD4, Antonio Maria Leone5, Gennaro Sardella, M.D.6, Pierfrancesco Agostoni, M.D.7, Jonathan Hill, M.B.B.S.8, Adrian P Banning9, Tomasz Roleder10, Anouar Belkacemi7, Giovanni L De Maria9 and Carlo Trani, MD2, (1)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy, (2)Catholic University of the Sacred Heart, Roma RM, Italy, (3)Tsuchiura Kyodo General Hospital, Tsuchiura, Japan, (4)CSK MSWiA, WARSAW, Warsaw, Poland, (5)Catholic University of the Sacred Heart, Rome, Italy, (6)Policlinico Umberto I, Roma, Italy, (7)University Medical Center Utrecht, Antwerp, Belgium, (8)King's College Hospital, London, United Kingdom, (9)Oxford Heart Center, Oxford University Hospitals, Oxford, United Kingdom, (10)Medical University of Silesia in Katowice, Katowice, Poland
Strict Versus No Fasting Prior to Cardiac Catheterization: A Prospective Evaluation of Safety and Clinical Outcomes: Can We Safely Have Our Patients Eat With Cardiac Catheterization— Nix or Allow: The CHOW NOW Study
Abhishek Mishra, M.D.1, Maninder Singh, M.D.2, Aadil Lodhi, M.D.2, Edo Kaluski, M.D., FSCAI2, Sudhakar Sattur, M.D.3 and Daniel P. Sporn, M.D.4, (1)Guthrie Clinic/Robert Packer Hospital, Greenville, NC, (2)Guthrie Robert Packer Hospital, Sayre, PA, (3)Robert Packer Hospital, Guthrie Health System, Sayre, PA, (4)Guthrie Clinic, Sayre, PA
See more of: Featured Sessions